Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:419392.
doi: 10.1155/2015/419392. Epub 2015 Aug 13.

Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China

Affiliations

Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China

Hui Pang et al. Biomed Res Int. 2015.

Abstract

Objectives: Several species of rapidly growing mycobacteria (RGM) are now recognized as human pathogens. However, limited data on effective drug treatments against these organisms exists. Here, we describe the species distribution and drug susceptibility profiles of RGM clinical isolates collected from four southern Chinese provinces from January 2005 to December 2012.

Methods: Clinical isolates (73) were subjected to in vitro testing with 31 antimicrobial agents using the cation-adjusted Mueller-Hinton broth microdilution method. The isolates included 55 M. abscessus, 11 M. fortuitum, 3 M. chelonae, 2 M. neoaurum, and 2 M. septicum isolates.

Results: M. abscessus (75.34%) and M. fortuitum (15.07%), the most common species, exhibited greater antibiotic resistance than the other three species. The isolates had low resistance to amikacin, linezolid, and tigecycline, and high resistance to first-line antituberculous agents, amoxicillin-clavulanic acid, rifapentine, dapsone, thioacetazone, and pasiniazid. M. abscessus and M. fortuitum were highly resistant to ofloxacin and rifabutin, respectively. The isolates showed moderate resistance to the other antimicrobial agents.

Conclusions: Our results suggest that tigecycline, linezolid, clofazimine, and cefmetazole are appropriate choices for M. abscessus infections. Capreomycin, sulfamethoxazole, tigecycline, clofazimine, and cefmetazole are potentially good choices for M. fortuitum infections. Our drug susceptibility data should be useful to clinicians.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Stout J. E., Gadkowski L. B., Rath S., Alspaugh J. A., Miller M. B., Cox G. M. Pedicure-associated rapidly growing mycobacterial infection: an endemic disease. Clinical Infectious Diseases. 2011;53(8):787–792. doi: 10.1093/cid/cir539. - DOI - PubMed
    1. Wang L., Zhang H., Ruan Y., et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. The Lancet. 2014;383(9934):2057–2064. doi: 10.1016/s0140-6736(13)62639-2. - DOI - PubMed
    1. El Helou G., Viola G. M., Hachem R., Han X. Y., Raad I. I. Rapidly growing mycobacterial bloodstream infections. The Lancet Infectious Diseases. 2013;13(2):166–174. doi: 10.1016/S1473-3099(12)70316-X. - DOI - PubMed
    1. Helguera-Repetto A. C., Chacon-Salinas R., Cerna-Cortes J. F., et al. Differential macrophage response to slow- and fast-growing pathogenic mycobacteria. BioMed Research International. 2014;2014:10. doi: 10.1155/2014/916521.916521 - DOI - PMC - PubMed
    1. Kheir W. J., Sheheitli H., Abdul Fattah M., Hamam R. N. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. BioMed Research International. 2015;2015:17. doi: 10.1155/2015/164989.164989 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources